Quality of Life in Vulvar Lichen Sclerosus Patients Treated With Long-Term Topical Corticosteroids
- 1 April 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 25 (2) , 158-165
Abstract
Objective: The aim of the study was to investigate the quality of life in vulvar lichen sclerosus (VLS) patients treated with long-term, individualized topical corticosteroids. Methods: A prospective cross-sectional study comparing new pretreatment and long-term treated VLS patients attending a dermatogynecology practice in Sydney, Australia. Participants were invited to complete the Vulvar Quality of Life Index (VQLI). The VQLI scores were compared between the 2 groups. Results: A total of 204 biopsy-proven VLS patients—68 new pretreatment and 136 treated patients on topical corticosteroids for 2 years or longer. Treated participants scored lower in all VQLI components, including total score (median = 2.0 [interquartile range {IQR} = 0.0–6.0] vs 13.5 [IQR = 7.5–22.0]; p < .001), symptoms (median = 0.5 [IQR = 0.0–0.5] vs 1.3 [IQR = 0.8–2.0]; p < .001), anxiety (median = 0.0 [IQR = 0.0–0.3] vs 0.8 [IQR = 1.1–2.0]; p < .001), activities of daily living (median = 0.2 [IQR = 0.0–0.3] vs 0.5 [IQR = 0.2–1.1]; p < .001), and sexuality (median = 0.0 [IQR = 0.0–0.7] vs 1.0 [IQR = 0.0–2.0]; p < .001). A higher proportion of treated patients achieved total scores of 0–5, representing nil to minimal impact of VLS on quality of life (98 [72.1%] vs 8 [11.8%]; p < .001). Mild and reversible adverse effects were developed in 11 patients (8.1%). Partially compliant patients were 12 times as likely to develop scarring progression than fully compliant patients (7 [22.6%] vs 2 [1.9%]; p < .001). Conclusions: Long-term, individualized topical corticosteroid treatment is safe and effective in maintaining disease remission and improves the quality of life of VLS patients. Fully compliant patients demonstrate better treatment outcomes than partially compliant patients.Keywords
This publication has 26 references indexed in Scilit:
- Vaginal Estrogen for Genitourinary Syndrome of MenopauseObstetrics & Gynecology, 2014
- The Impact of Vulvar Lichen Sclerosus on Sexual DysfunctionJournal of Women's Health, 2014
- Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized studyBritish Journal of Dermatology, 2013
- Quality of life in Dutch women with lichen sclerosusBritish Journal of Dermatology, 2012
- Health-Related Quality of Life and Patient-Defined Benefit of Clobetasol 0.05% in Women with Chronic Lichen Sclerosus of the VulvaDermatology, 2011
- The Treatment of Vulvar Lichen Sclerosus and Female Sexual DysfunctionThe Journal of Sexual Medicine, 2011
- The effect of vulvar lichen sclerosus on quality of life and sexual functioningJournal of Psychosomatic Obstetrics & Gynecology, 2010
- Long‐term management of vulval lichen sclerosus in adult womenAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2010
- Qualitative study of women’s anxiety and information needs after a diagnosis of cervical dysplasiaJournal of Public Health, 2010
- A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal womenMenopause, 2006